2-Bromo-4,5-methylenedioxyamphetamine: Difference between revisions
Jump to navigation
Jump to search
m Protected "2-Bromo-4,5-methylenedioxyamphetamine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
||
| Line 21: | Line 21: | ||
==Reference== | ==Reference== | ||
{{reflist}} | {{reflist|2}} | ||
== See also == | == See also == | ||
Latest revision as of 13:47, 4 September 2012
| 2-bromo-4,5-methylenedioxyamphetamine | |
|---|---|
| Chemical name | 2-bromo-4,5-methylenedioxyamphetamine or 2-(2-bromo-4,5-methylenedioxyphenyl)ethan-1-methyl-amine |
| Chemical formula | C11H17NO2Br |
| Molecular mass | ? |
| SMILES | ? |
| File:2-bromo-4,5-methylenedioxyamphetamine.png | |
2-Bromo-4,5-methylenedioxyamphetamine is a lesser-known psychedelic drug and a substituted amphetamine. It was first synthesized by Alexander Shulgin. In his book PIHKAL (Phenethylamines I Have Known and Loved), the dosage range is listed as 350 mgs, and the duration unknown. It produces few to no effects [1]. Very little data exists about its pharmacological properties, metabolism, and toxicity.